CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $15,378,206
- in 4 filings, $15.4M under 10b5-1 plans
Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-13 | Arbuckle Stuart A EVP, COO | Exercise or conversion 10b5-1 | +8,603 | $187.53 | $1.6M | 65,159 |
| 2023-12-13 | Arbuckle Stuart A EVP, COO | Sale 10b5-1 | −8,603 | $399.00 | $3.4M | 56,556 |
| 2023-12-13 | Arbuckle Stuart A EVP, COO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −8,603 | 0 | ||
| 2023-12-05 | Thornberry Nancy Director | Grant or award | +1,136 | 1,136 |
Page 27 of 27 · 524 trades